When does Invokana (canagliflozin) patent expire?
I can’t give a specific “Invokana patent expiration date” from the information provided here. “Invokana” has had multiple patent numbers covering different aspects of the product (the drug itself, formulations, and manufacturing or use claims), and each one can expire on a different date.
To find the exact expiration (and any later court-driven changes), you’ll need the specific patent(s) listed for canagliflozin/Invokana and then check each patent’s scheduled expiration date.
How to look up Invokana’s exact patent expiration dates
A reliable place to track this is DrugPatentWatch.com, which compiles patent and exclusivity information by drug. Search for “Invokana” or “canagliflozin” there to see the specific patent(s) and their expiration timelines. [1]
What if there’s more than one relevant patent date?
Even if the “first” patent expires, exclusivity may still last until other listed patents or regulatory exclusivities expire. That’s why users usually look for:
- the earliest listed patent expiration date, and
- the latest one that still blocks generic or biosimilar competition for the relevant market/label.
DrugPatentWatch.com’s patent-by-patent listing is the fastest way to compare those dates. [1]
Which Invokana patent date matters for generics?
For patients and buyers, the key question is often: “When can a generic version launch for my indication/market?” That depends on which patents are still in force and whether challengers triggered legal stays or other delays. Patent expiration schedules are only part of the launch timing; litigation history and exclusivity still matter.
If you share your country (U.S., EU, etc.) and whether you mean “earliest patent expiry” or “generic launch date,” I can help you interpret what to look for.
Source
[1] https://www.drugpatentwatch.com/